<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7981088</article-id><article-id pub-id-type="pmc">2033699</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Miles</surname><given-names>D. W.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Happerfield</surname><given-names>L. C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gillibrand</surname><given-names>R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bobrow</surname><given-names>L. G.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gregory</surname><given-names>W. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rubens</surname><given-names>R. D.</given-names></name></contrib></contrib-group><aff>ICRF Clinical Oncology Unit, Guy's Hospital, London, UK.</aff><pub-date pub-type="ppub"><month>12</month><year>1994</year></pub-date><volume>70</volume><issue>6</issue><fpage>1272</fpage><lpage>1275</lpage><abstract><p>Sialyl-Tn (STn) is a carcinoma-associated carbohydrate determinant expressed on cancer-associated mucins and has the structure NANA alpha(2-6)alpha GalNAc. Expression of STn in colon and ovarian cancer is associated with a poor prognosis independent of tumour grade, stage or histological type. We have examined 237 cases of primary breast cancer for expression of this antigen using the antibody HB-STn (Dako). The frequency of STn expression was 31% in the whole group, 36% in the node-negative and 28% in the node-positive group. Survival was lower, but not significantly so, in the STn-positive group (P = 0.07), but this effect was highly significant for patients with node-positive disease (P &#x0003c; 0.002), the curves for node-negative disease being coincident (P = 0.31). In node-positive disease the effect was limited to those receiving adjuvant chemotherapy (P = 0.001). In a multivariate (Cox) analysis on the whole group STn staining, combined with adjuvant chemotherapy, showed a highly significant correlation with survival. In STn-negative cases, adjuvant chemotherapy improved survival (relative risk 2.3, 95% confidence intervals 1.4-3.9), whereas adjuvant chemotherapy did not influence survival in patients which expressed STn (relative risk 1.1, 95% confidence intervals 0.6-2.2). Thus, by either direct or indirect mechanisms, STn positivity appears to be a marker of resistance to adjuvant chemotherapy.</p><sec sec-type="scanned-figures"><title>Images</title><fig id="F1"><label>Figure 1</label><graphic xlink:href="brjcancer00058-0241-a" xlink:role="1273"/></fig></sec></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="brjcancer00058-0240.tif" xlink:title="scanned-page" xlink:role="1272" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00058-0241.tif" xlink:title="scanned-page" xlink:role="1273" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00058-0242.tif" xlink:title="scanned-page" xlink:role="1274" mimetype="image" mime-subtype="tiff"/><graphic xlink:href="brjcancer00058-0243.tif" xlink:title="scanned-page" xlink:role="1275" mimetype="image" mime-subtype="tiff"/></supplementary-material></body></article>

